Abstract |
Between June, 1979 and December, 1983, 23 adult patients with non-metastatic soft tissue sarcoma were treated with induction chemotherapy since local spread precluded primary conservative surgery. Eighteen patients received a combined cyclophosphamide, vincristine, adriamycin and dacarbazine treatment and 5, a combined adriamycin, cis-platinum and vindesine treatment. Both drug combinations exhibited toxic effects, notably on blood and digestive tract. However, tumoral volume was reduced by 50 p. cent or more in 14/23 patients, including 2 complete remissions; the course of the disease remained unchanged under treatment in only 3 cases. Chemotherapy facilitated surgical excision in 14 patients, and subsequent radiotherapy resulted in complete remission in 13 of these. None of the 13 patients relapsed during a mean follow-up period of 12 months (range: 3 to 48 months). Among the 9 patients who could not be operated upon, 5 benefited from radiotherapy with satisfactory local control, but only one still remains in complete remission. Thus, induction chemotherapy made it possible to achieve local control in two-thirds of patients with locally advanced sarcoma. However, a more prolonged follow-up is necessary to confirm that these results are long-lasting and to determine the effects of chemotherapy, if any, on the metastatic potential of these tumours.
|
Authors | D Marée, C Hocke, N B Bui, J M Coindre, P Tramond, A Avril, P Mage, J Chauvergne, P Richaud |
Journal | Presse medicale (Paris, France : 1983)
(Presse Med)
Vol. 14
Issue 19
Pg. 1069-72
(May 11 1985)
ISSN: 0755-4982 [Print] France |
Vernacular Title | Traitement loco-régional conservateur des sarcomes des tissus mous chez l'adulte après chimiothérapie d'induction. |
PMID | 3158961
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Vincristine
- Vinblastine
- Dacarbazine
- Doxorubicin
- Cyclophosphamide
- Cisplatin
- Vindesine
|
Topics |
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols
(adverse effects, therapeutic use)
- Cisplatin
(administration & dosage)
- Combined Modality Therapy
- Cyclophosphamide
(administration & dosage)
- Dacarbazine
(administration & dosage)
- Doxorubicin
(administration & dosage)
- Female
- Follow-Up Studies
- Humans
- Male
- Middle Aged
- Neoplasm Staging
- Sarcoma
(drug therapy, radiotherapy, surgery)
- Soft Tissue Neoplasms
(drug therapy, radiotherapy, surgery)
- Vinblastine
(administration & dosage, analogs & derivatives)
- Vincristine
(administration & dosage)
- Vindesine
|